OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axis
Yan-Ran Bi, Ruiling Zheng, Jiahao Hu, et al.
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 479-494
Open Access | Times Cited: 12
Yan-Ran Bi, Ruiling Zheng, Jiahao Hu, et al.
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 479-494
Open Access | Times Cited: 12
Showing 12 citing articles:
Non-coding RNAs as mediators of epithelial - Mesenchymal transition (EMT) in metastatic colorectal cancers
Aisha Shigna Nadukkandy, Britny Blaize, C. Selvaa Kumar, et al.
Cellular Signalling (2025) Vol. 127, pp. 111605-111605
Closed Access | Times Cited: 1
Aisha Shigna Nadukkandy, Britny Blaize, C. Selvaa Kumar, et al.
Cellular Signalling (2025) Vol. 127, pp. 111605-111605
Closed Access | Times Cited: 1
Improvements in Exercise for Alzheimer’s Disease: Highlighting FGF21-Induced Cerebrovascular Protection
Juan Wang, Xiangyuan Meng, Yang Jialun, et al.
Neurochemical Research (2025) Vol. 50, Iss. 2
Closed Access
Juan Wang, Xiangyuan Meng, Yang Jialun, et al.
Neurochemical Research (2025) Vol. 50, Iss. 2
Closed Access
Advances on the therapeutic potential of cell receptor activation in glioblastoma
Gerson Gabriel Contreras-Chávez, Luis Ángel Zapi-Colín, José Antonio Estrada, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Gerson Gabriel Contreras-Chávez, Luis Ángel Zapi-Colín, José Antonio Estrada, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Matrix metallopeptidase 2-responsive curcumin-loaded nanoparticles-induced signal transducer and activator of transcription 3 inhibition suppresses glioblastoma multiforme growth via enhancing nuclear factor erythroid 2-related factor 2 activity
Fujie Jia, Yingpeng Peng, Xiaobing Li, et al.
International Journal of Biological Macromolecules (2025) Vol. 307, pp. 141998-141998
Open Access
Fujie Jia, Yingpeng Peng, Xiaobing Li, et al.
International Journal of Biological Macromolecules (2025) Vol. 307, pp. 141998-141998
Open Access
The landscape of FGFR-TACC fusion in adult glioblastoma: from bench to bedside
Jing Liu, Zheng Wang
Mutation Research/Reviews in Mutation Research (2025), pp. 108536-108536
Closed Access
Jing Liu, Zheng Wang
Mutation Research/Reviews in Mutation Research (2025), pp. 108536-108536
Closed Access
A novel L-shaped ortho-quinone analog suppresses glioblastoma progression by targeting acceleration of AR degradation and regulating PI3K/AKT pathway
Tao Zhang, Weidong Pan, Xin Tan, et al.
Biochemical Pharmacology (2024) Vol. 226, pp. 116398-116398
Closed Access | Times Cited: 2
Tao Zhang, Weidong Pan, Xin Tan, et al.
Biochemical Pharmacology (2024) Vol. 226, pp. 116398-116398
Closed Access | Times Cited: 2
Forsythiaside A ameliorates bleomycin‐induced pulmonary fibrosis by inhibiting oxidative stress and apoptosis
Fan Yang, Qinqin Zhang, Xi Wang, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 8
Open Access | Times Cited: 2
Fan Yang, Qinqin Zhang, Xi Wang, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 8
Open Access | Times Cited: 2
Targeting CERS6-AS1/FGFR1 axis as synthetic vulnerability to constrain stromal cells supported proliferation in Mantle cell lymphoma
Udita Jindal, Mukesh Mamgain, Uttam Kumar Nath, et al.
Leukemia (2024) Vol. 38, Iss. 10, pp. 2196-2209
Closed Access | Times Cited: 1
Udita Jindal, Mukesh Mamgain, Uttam Kumar Nath, et al.
Leukemia (2024) Vol. 38, Iss. 10, pp. 2196-2209
Closed Access | Times Cited: 1
Pharmacological and Biological Targeting of FGFR1 in Cancer
Shuai Fan, Yuxin Chen, Wenyu Wang, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 11, pp. 13131-13150
Open Access | Times Cited: 1
Shuai Fan, Yuxin Chen, Wenyu Wang, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 11, pp. 13131-13150
Open Access | Times Cited: 1
The Complexity and Significance of Fibroblast Growth Factor (FGF) Signaling for FGF-Targeted Cancer Therapies
A. Nguyen, Caroline O. Facey, Bruce M. Boman
Cancers (2024) Vol. 17, Iss. 1, pp. 82-82
Open Access | Times Cited: 1
A. Nguyen, Caroline O. Facey, Bruce M. Boman
Cancers (2024) Vol. 17, Iss. 1, pp. 82-82
Open Access | Times Cited: 1
Red fermented rice elution fractions inhibits cancer cell proliferation by regulating the FGFR1/PI3K/AKT signaling pathway
Zhongyuan Guo, Bingli Zhao, Song Ya-fang, et al.
Fitoterapia (2024) Vol. 177, pp. 106079-106079
Closed Access
Zhongyuan Guo, Bingli Zhao, Song Ya-fang, et al.
Fitoterapia (2024) Vol. 177, pp. 106079-106079
Closed Access
Design, Synthesis, and Biological Evaluation of 3-Amino-pyrazine-2-carboxamide Derivatives as Novel FGFR Inhibitors
Jia Zheng, Wei Zhang, Dan Ni, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 11, pp. 2019-2031
Closed Access
Jia Zheng, Wei Zhang, Dan Ni, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 11, pp. 2019-2031
Closed Access
